Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamic Interactions Between Remifentanil and Dexmedetomidine (PIRAD)

NCT03143972 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03143972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamic Interactions Between Remifentanil and Dexmedetomidine (PIRAD)
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Completed
Start date
June 28, 2017
Completion date
February 23, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia